Hospira Inc News Headlines

HSP 
$62.44
*  
2.19
3.63%
Get HSP Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading HSP now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    HSP After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Is Boston Scientific (BSX) Worth Adding to Your Portfolio? - Analyst Blog
12/16/2014 4:50:00 PM - Zacks.com


2015 Healthcare Sector Predictions
12/16/2014 6:50:00 AM - Seeking Alpha


Danone To Retain Medical Nutrition Unit, Announces Management Changes
12/12/2014 7:43:00 AM - RTT News


Update: Cubist Pharmaceuticals Is Acquired By Merck, Gains Remain For Investors
12/11/2014 12:31:00 AM - Seeking Alpha


Merck-Cubist Deal On Despite Patent Setback, Shares Fall - Analyst Blog
12/10/2014 4:30:00 PM - Zacks.com


Cubist Shoots Up on $9.5 Billion Buyout Offer from Merck - Analyst Blog
12/9/2014 4:30:00 PM - Zacks.com


Merck Reaffirms Commitment to Cubist Deal Despite Patent Ruling -- Update
12/9/2014 2:06:00 PM - Dow Jones Business News


Merck Committed To Cubist Pharma Acquisition Despite Patent Ruling
12/9/2014 9:53:00 AM - RTT News


Merck Reaffirms Commitment to Cubist Deal Despite Patent Ruling
12/9/2014 9:35:00 AM - Dow Jones Business News


Health Care Sector Update for 12/09/2014: ARIA, CBST, CELG
12/9/2014 8:50:21 AM - MT Newswires


Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 6th Update
12/8/2014 10:01:00 PM - Dow Jones Business News


Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 5th Update
12/8/2014 6:16:00 PM - Dow Jones Business News


Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 4th Update
12/8/2014 6:06:00 PM - Dow Jones Business News


You Can Outsmart Wall Street With These 3 Stocks
12/6/2014 12:32:02 PM - Motley Fool


Bloomberg: Danone Mulls Sale Of 20% Stake In Japan's Yakult Honsha For $2 Bln
11/26/2014 10:10:00 AM - RTT News


Earnings Triple Plays
11/12/2014 2:54:00 AM - Seeking Alpha


Hospira Inc.'s Third-Quarter Earnings: The 3 Key Takeaways
11/7/2014 11:53:02 AM - Motley Fool


Stock Market News for November 07, 2014 - Market News
11/7/2014 10:10:00 AM - Zacks.com


Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
11/7/2014 9:25:00 AM - Zacks.com


MARKET SNAPSHOT: U.S. Stocks Close At Record Levels
11/6/2014 4:26:00 PM - Dow Jones Business News


Hospira Beats on Earnings & Sales in Q3, Narrows Guidance - Analyst Blog
11/6/2014 2:53:00 PM - Zacks.com


S&P 500 Movers: GNW, WFM
11/6/2014 12:41:38 PM - BNK Invest


MARKET SNAPSHOT: U.S. Stocks Rebound; Tesla Surges
11/6/2014 11:56:00 AM - Dow Jones Business News


Hospira Q3 14 Earnings Conference Call At 9:00 AM ET
11/6/2014 8:00:00 AM - RTT News


Will AVEO Pharmaceuticals (AVEO) Surprise this Earnings? - Analyst Blog
11/5/2014 5:10:00 PM - Zacks.com